ERBB2 and breast carcinoma: HER2 is a member of the human epidermal growth factor receptor family, and its overexpression has been reported in various cancer types, especially human breast cancers (∼15–30%) and gastric cancers (7–34%) (Iqbal and Iqbal, 2014).